Fidelity Investments’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,240,524
Closed -$35.3M 5818
2023
Q4
$35.3M Sell
2,240,524
-3,213,424
-59% -$30.9M ﹤0.01% 1423
2023
Q3
$42.3M Sell
5,453,948
-1,249,174
-19% -$10.4M ﹤0.01% 1308
2023
Q2
$66.6M Buy
6,703,122
+700,120
+12% +$5.6M 0.01% 1158
2023
Q1
$34.8M Buy
6,003,002
+1,117,631
+23% +$9.66M ﹤0.01% 1392
2022
Q4
$38.8M Buy
4,885,371
+1,565,734
+47% +$6.72M ﹤0.01% 1354
2022
Q3
$10.5M Buy
3,319,637
+240,494
+8% +$1.5M ﹤0.01% 1877
2022
Q2
$17.6M Buy
3,079,143
+822,348
+36% +$6.42M ﹤0.01% 1700
2022
Q1
$15.9M Buy
2,256,795
+828,899
+58% +$13M ﹤0.01% 1899
2021
Q4
$32.7M Sell
1,427,896
-22,354
-2% -$577K ﹤0.01% 1588
2021
Q3
$42.9M Buy
+1,450,250
New +$49.2M ﹤0.01% 1477

Fidelity Investments's ICVX Position: Q1 2024 in Review

Fidelity Investments sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 2,240,524 shares — an estimated $35.3M sold.

Fidelity Investments first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $66.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Fidelity Investments reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fidelity Investments sold 2,240,524 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $35.3M.
  • Fidelity Investments first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Fidelity Investments's Icosavax, Inc. Common Stock position peaked at $66.6M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.